Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms

Combining methylated SDC2 test in stool DNA, fecal immunochemical test, and tumor markers improves early detection of colorectal neoplasms

ObjectiveTo explore the value of testing methylated SDC2 (SDC2) in stool DNA combined with fecal immunochemical test (FIT) and serum tumor markers (TM) for the early detection of colorectal neoplasms.MethodsA total of 533 patients, including 150 with CRC (67 with early-stage CRC), 23 with APL, 85 wi...

Full description

Bibliographic Details
Main Authors:	Tao Zeng, Zhongchao Huang, Xufa Yu, Li Zheng, Tao Liu, Boyu Tian, Siyu Xiao, Jiahui Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Oncology
Subjects:	SDC2 fecal immunochemical test colorectal neoplasms tumor markers combined testing
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1166796/full

Similar Items

The advantages of the immunochemical test in detecting hidden blood in the stool
by: S. V. Vasiliev, et al.
Published: (2015-12-01)

Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
by: Hongli Xu, et al.
Published: (2022-08-01)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
by: P. H. A. Wisse, et al.
Published: (2022-12-01)

A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening
by: Ze Y, et al.
Published: (2023-03-01)

Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test
by: María Angeles Gutierrez-Stampa, et al.
Published: (2020-08-01)

Clinical Effectiveness of Faecal Immunochemical Test in the Early Detection of Colorectal Cancer—An Umbrella Review
by: Jakub Świtalski, et al.
Published: (2022-09-01)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
by: Carrie M. Nielson, et al.
Published: (2018-09-01)

Risk of colorectal cancer in patients with positive results of fecal immunochemical test performed within 5 years since the last colonoscopy
by: Yoon Suk Jung, et al.
Published: (2021-09-01)

Accuracy of a faecal immunochemical test in patients under colonoscopy surveillance of colorectal adenoma and cancer
by: Louise Olsson, et al.
Published: (2023-06-01)

Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening
by: Tim L. Kortlever, et al.
Published: (2021-09-01)

Possible Value of Faecal Immunochemical Test (FIT) When Added in Symptomatic Patients Referred for Colonoscopy: A Systematic Review
by: Henrike Jacoba Brands, et al.
Published: (2023-03-01)

Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort
by: Brenner H, et al.
Published: (2018-04-01)

Factors Associated with the Use of Fecal Immunochemical Tests and Colonoscopy in the INSEF Portuguese Population
by: Fábio Sousa Gomes, et al.
Published: (2021-06-01)

Detection of Upper Gastrointestinal Disorders in Patients with Positive Fecal Immunochemical Test (FIT) and Normal Colonoscopy: A Cross-Sectional Study
by: Sahar Ravanshad, et al.
Published: (2024-03-01)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
by: Dong Ju Kim, et al.
Published: (2018-10-01)

Performance of the Fecal Immunochemical Test in Detecting Advanced Colorectal Neoplasms and Colorectal Cancers in People Aged 40–49 Years: A Systematic Review and Meta-Analysis
by: Jen-Hao Yeh, et al.
Published: (2023-05-01)

Interval Cancer Rate and Diagnostic Performance of Fecal Immunochemical Test According to Family History of Colorectal Cancer
by: Yoon Suk Jung, et al.
Published: (2020-10-01)

Comparison between the Effectiveness Fecal Immunochemical Test and Colonoscopy As A Tool For Colorectal Cancer Early Detection
by: Yossi Andila, et al.
Published: (2022-03-01)

Preference and Experience of Colonic Examination for Participants Presenting to Hospitals with a Positive Fecal Immunochemical Test Result
by: Kato T, et al.
Published: (2020-10-01)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
by: Yinan Ren, et al.
Published: (2022-08-01)

Faecal Immunochemical Testing to Detect Colorectal Cancer in Symptomatic Patients: A Diagnostic Accuracy Study
by: Farzana Rahman, et al.
Published: (2023-07-01)

Performance of the fecal immunochemical test for colorectal cancer and advanced neoplasia in individuals under age 50
by: Emily Heer, et al.
Published: (2023-04-01)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
by: Efrat L. Amitay, et al.
Published: (2019-03-01)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
by: Jun Kato, et al.
Published: (2016-01-01)

Diagnostic accuracy of risk assessment and fecal immunochemical test in colorectal cancer screening: Results from a population‐based program and meta‐analysis
by: Ziyang Wang, et al.
Published: (2023-09-01)

Use of Antiplatelet Agents Decreases the Positive Predictive Value of Fecal Immunochemical Tests for Colorectal Cancer but Does Not Affect Their Sensitivity
by: Yoonsuk Jung, et al.
Published: (2021-06-01)

Positive faecal immunochemical test predicts the onset of inflammatory bowel disease: A nationwide, propensity score-matched study
by: Eunyoung Lee, et al.
Published: (2023-02-01)

Diagnostic accuracy of DNA-based SDC2 methylation test in colorectal cancer screening: a meta-analysis
by: Lixing Wang, et al.
Published: (2022-06-01)

Evaluation of the Effectiveness of Colonoscopy, Fecal Immunochemical Test and Risk-adapted Screening Strategies in Population-based Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial
by: CHEN Hongda, et al.
Published: (2023-01-01)

Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test
by: Yan-Mei Liu, et al.
Published: (2023-12-01)

Positive Fecal Immunochemical Test Results Are Associated with Increased Risks of Esophageal, Stomach, and Small Intestine Cancers
by: Yoon Suk Jung, et al.
Published: (2020-07-01)

Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study
by: Terhaar sive Droste Jochim S, et al.
Published: (2012-07-01)

Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial
by: Elizabeth A. O’Connor, et al.
Published: (2020-01-01)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer
by: Zhang W, et al.
Published: (2021-04-01)

Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
by: Karen N. Barnett, et al.
Published: (2021-11-01)

A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA
by: Liang Ma, et al.
Published: (2022-04-01)

Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
by: Tae Jeong Oh, et al.
Published: (2017-12-01)

Profiling small RNAs in fecal immunochemical tests: is it possible?
by: Einar Birkeland, et al.
Published: (2023-10-01)

SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer [Corrigendum]
by: Zhang W, et al.
Published: (2022-05-01)

Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity
by: Gemma Ibáñez-Sanz, et al.
Published: (2022-02-01)